As a prototypic Th1 cytokine, interferon gamma (IFN-γ) has been used as adjunctive therapy for patients with both hematogenously disseminated candidiasis and multidrug-resistant OPC (23, 24). The gene discussed is IFNG; the disease is disseminated candidiasis.